Announced
Completed
Synopsis
Cooper Consumer Health, an independent over-the-counter drug manufacturer, completed the acquisition of the OTC business of Viatris, an American global pharmaceutical and healthcare company, for $2.17bn. "Closing the divestiture of our OTC business is a significant milestone in the execution of our strategic plan. With all our previously announced divestitures now substantially complete, Viatris is stronger and more streamlined. We look forward to an exciting future in which we continue to build on our very strong base business and add to our innovative product pipeline to drive strong future revenue growth and positively affect even more patients' lives worldwide," Scott A. Smith, Viatris Chief Executive Officer.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.